NextCure, Inc.
NXTC
$12.04
-$0.52-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.01M | -60.93M | -49.52M | -55.65M | -58.52M |
| Total Depreciation and Amortization | 2.49M | 2.66M | 2.73M | 2.87M | 3.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.93M | 4.56M | 5.39M | 7.45M | 7.88M |
| Change in Net Operating Assets | 2.64M | -426.00K | 207.00K | 4.53M | 3.11M |
| Cash from Operations | -48.94M | -54.13M | -41.19M | -40.81M | -44.51M |
| Capital Expenditure | 34.00K | -136.00K | -437.00K | -474.00K | -521.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.48M | 36.25M | 44.96M | 55.78M | 53.03M |
| Cash from Investing | 26.51M | 36.12M | 44.52M | 55.31M | 52.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.06M | 2.06M | 142.00K | 143.00K | 178.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.06M | 2.06M | 142.00K | 143.00K | 178.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.38M | -15.96M | 3.47M | 14.64M | 8.18M |